Search - tctmd.com

Displaying 101 - 120 of 184

Sort: Relevancy | Date

Presentation TVT 2019

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

Percutaneous Aortic Valve Replacement: Life-Threatening Complication and Out-of-the-Box Solution

Presenter: Nagendra Chouhan

June 13, 2019

Presentation TVT 2019

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Presenter: Luis Dallan

June 13, 2019

Presentation TVT 2019

Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Transcatheter Aortic Valve Replacement

Presenter: Setri Fugar

June 13, 2019

Presentation TVT 2019

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Presenter: Aaqib H Malik

June 13, 2019

Presentation TVT 2019

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A 2-Year Analysis From the SURTAVI Trial

Presenter: Mark Tuttle

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve Replacement Using the CoreValve Prosthesis for the Treatment of Severe Aortic Regurgitation: A Single-Center Learning Curve Over 6 Years

Presenter: Giselle Baquero

June 13, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Caitlin E. Cox

June 07, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

Presentation ARCH 2019

Alternative Access Considerations for Transcatheter Valve Replacement

Presenter: Hersh Maniar

April 11, 2019

Advertisement

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Percutaneous Aortic Valve Replacement: Life-Threatening Complication and Out-of-the-Box Solution

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Transcatheter Aortic Valve Replacement

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A 2-Year Analysis From the SURTAVI Trial

Transcatheter Aortic Valve Replacement Using the CoreValve Prosthesis for the Treatment of Severe Aortic Regurgitation: A Single-Center Learning Curve Over 6 Years

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Alternative Access Considerations for Transcatheter Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content